TrialJournal of gastroenterology2014

A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Kazunari Tominaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.